Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 5/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | BCR | P11274 | 1/20 | 0.36 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | NPY2R | P49146 | 1/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.35 |
| ▸ | TACR3 | P29371 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2376134 | 1.00 | OPRK1 (0.40) | OPRK1TRPV1KCNH2HRH3HDAC1 | |
| SCHEMBL2375763 | 0.99 | OPRK1 (0.39) | OPRK1TRPV1KCNH2HRH3HDAC1 | |
| SCHEMBL2375767 | 0.99 | OPRK1 (0.39) | OPRK1TRPV1KCNH2HRH3HDAC1 | |
| SCHEMBL2376581 | 0.93 | TRPV1 (0.37) | OPRK1TRPV1HDAC1ABL1BCR | |
| SCHEMBL2376579 | 0.93 | TRPV1 (0.37) | OPRK1TRPV1HDAC1ABL1BCR | |
| SCHEMBL2374202 | 0.91 | NOS3 (0.40) | OPRK1TRPV1KCNH2HRH3HDAC1 | |
| SCHEMBL2374204 | 0.91 | NOS3 (0.40) | OPRK1TRPV1KCNH2HRH3HDAC1 | |
| SCHEMBL2374375 | 0.90 | NOS3 (0.40) | OPRK1TRPV1KCNH2HRH3HDAC1 | |
| SCHEMBL2374379 | 0.90 | NOS3 (0.40) | OPRK1TRPV1KCNH2HRH3HDAC1 | |
| SCHEMBL2375324 | 0.90 | TRPV1 (0.40) | TRPV1HDAC1TRPM8MDM2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110224210-A1 | NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS | ACTELION PHARMACEUTICALS LTD. (CH) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224210-A1 | NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS | CTSA, BECN1, HDAC6 | OPRK1 4074/4885TRPV1 2628/4885KCNH2 4177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.